ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

OPTN OptiNose Inc

0.8779
0.0003 (0.03%)
プレマーケット
最終更新日: 18:35:43
15分遅延
名称 銘柄コード 市場 種別
OptiNose Inc OPTN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0003 0.03% 0.8779 18:35:43
始値 安値 高値 終値 前日終値
0.8776
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2520:00GLOBEOptinose Provides Corporate Update on XHANCE Launch and..
2024/4/0505:01GLOBEOptinose to Present at the Needham Virtual Healthcare..
2024/3/1604:34GLOBEXHANCE Approved by FDA as First and Only Medication..
2024/3/0906:10EDGAR2Form 8-K - Current report
2024/3/0806:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0721:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0721:00GLOBEOptinose Reports Fourth Quarter and Full Year 2023 Financial..
2024/3/0721:00EDGAR2Form 8-K - Current report
2024/3/0106:40GLOBEOptinose Announces Reporting Date for Fourth Quarter 2023..
2024/3/0106:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2321:08EDGAR2Form 8-K - Current report
2024/2/2306:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1510:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1407:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0204:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3106:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1902:00GLOBEOptinose Announces the Publication of ReOpen Phase 3..
2023/12/2206:11EDGAR2Form 8-K - Current report
2023/12/2102:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2102:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0622:48DJNOptinose Shares Slide Premarket as FDA Extends Xhance Review
2023/12/0621:02EDGAR2Form 8-K - Current report
2023/12/0621:00GLOBEOptinose Announces 3-Month Extension of FDA Review Period..
2023/11/2223:00GLOBEOptinose to Present at the 35th Annual Piper Sandler..
2023/11/0921:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:02EDGAR2Form 8-K - Current report
2023/11/0921:00GLOBEOptinose Reports Third Quarter 2023 Financial Results and..
2023/10/2721:00GLOBEOptinose Announces Reporting Date for Third Quarter 2023..
2023/9/2222:01GLOBEOptinose to Present at the 2023 Cantor Global Healthcare..
2023/9/2008:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2008:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1813:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/1105:05EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1020:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1020:02EDGAR2Form 8-K - Current report
2023/8/1020:00GLOBEOptinose Reports Second Quarter 2023 Financial Results and..
2023/7/2720:27EDGAR2Form 8-K - Current report
2023/7/2720:00GLOBEOptinose Announces Preliminary Second Quarter 2023 XHANCE..
2023/6/1705:08GLOBEOptinose Announces Inducement Grant Under Nasdaq Listing..
2023/6/0302:00GLOBEOptinose to Present at the Jefferies Healthcare Conference
2023/5/1120:00GLOBEOptinose Reports First Quarter 2023 Financial Results and..
2023/5/0420:00GLOBEOptinose Announces FDA Acceptance of Supplemental New Drug..

最近閲覧した銘柄

Delayed Upgrade Clock